Search results
Showing results for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
Immunisation Update Training Programme Tues 10 Nov 2026
Immunisation Update Training Programme Tues 10 Nov 2026
Draft Programme - Immunisation Update Tues 10 Nov 26.pdf (690 KB)
Immunisation Update Training Programme Wed 11 Nov 2026
Immunisation Update Training Programme Wed 11 Nov 2026
Draft Programme - Immunisation Update Wed 11 Nov 26.pdf (687 KB)

